Company / SG&A Expense
GERON CORP SG&A Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$145.7M
FY2024
5-year range
$18.7M / $145.7M
FY2020-FY2024
Trend
+110.8%
vs FY2023
Sector context
#95 of 213
Health Care
What the data says
At $146M, GERON CORP's sg&a expense ranks #119 of 213 in the Health Care sector. SG&A Expense has increased for 4 consecutive years, from $19M in FY2020 to $146M in FY2024.
Based on SEC 10-K filings.
$146M in FY2024 with a 5-year CAGR of +49.9%.
Increased from $44M to $146M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +91.1%
- 5-Year CAGR
- +49.9%
- 10-Year CAGR
- -
Sector benchmark
#119 of 213 in Health CareTop 55% of 213This company $145.7M Sector average $722.3M
▼
-79.8% below sector average
Key checks
Key Insights
- GERON CORP's sg&a expense has grown for 4 consecutive years.
- 5-year CAGR of +49.9%, indicating consistent growth.
- In FY2024, sg&a expense increased 110.8% year-over-year.
- Ranks #95 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $145.7M | +110.8% |
| FY2023 | $69.1M | +58.5% |
| FY2022 | $43.6M | +108.8% |
| FY2021 | $20.9M | +11.7% |
| FY2020 | $18.7M | -3.0% |
| FY2019 | $19.3M | +2.8% |
| FY2018 | $18.8M | +5.4% |
| FY2017 | $17.8M | +6.2% |
| FY2016 | $16.8M | +7.3% |
| FY2015 | $15.6M | -23.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026